JP2024529466A5 - - Google Patents

Info

Publication number
JP2024529466A5
JP2024529466A5 JP2024505116A JP2024505116A JP2024529466A5 JP 2024529466 A5 JP2024529466 A5 JP 2024529466A5 JP 2024505116 A JP2024505116 A JP 2024505116A JP 2024505116 A JP2024505116 A JP 2024505116A JP 2024529466 A5 JP2024529466 A5 JP 2024529466A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
amino
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024505116A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529466A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038730 external-priority patent/WO2023009759A2/en
Publication of JP2024529466A publication Critical patent/JP2024529466A/ja
Publication of JP2024529466A5 publication Critical patent/JP2024529466A5/ja
Pending legal-status Critical Current

Links

JP2024505116A 2021-07-30 2022-07-28 抗体薬物コンジュゲート及びその使用方法 Pending JP2024529466A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163227666P 2021-07-30 2021-07-30
US63/227,666 2021-07-30
US202263322914P 2022-03-23 2022-03-23
US63/322,914 2022-03-23
US202263344932P 2022-05-23 2022-05-23
US63/344,932 2022-05-23
PCT/US2022/038730 WO2023009759A2 (en) 2021-07-30 2022-07-28 Antibody-drug conjugates and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024529466A JP2024529466A (ja) 2024-08-06
JP2024529466A5 true JP2024529466A5 (cg-RX-API-DMAC10.html) 2025-08-05

Family

ID=85088249

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024505498A Pending JP2024529506A (ja) 2021-07-30 2022-07-28 ネクチン-4に特異的な抗体および抗体複合体、並びにそれらの使用方法
JP2024505116A Pending JP2024529466A (ja) 2021-07-30 2022-07-28 抗体薬物コンジュゲート及びその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2024505498A Pending JP2024529506A (ja) 2021-07-30 2022-07-28 ネクチン-4に特異的な抗体および抗体複合体、並びにそれらの使用方法

Country Status (9)

Country Link
US (2) US20250121090A1 (cg-RX-API-DMAC10.html)
EP (3) EP4377320A4 (cg-RX-API-DMAC10.html)
JP (2) JP2024529506A (cg-RX-API-DMAC10.html)
KR (2) KR20240040098A (cg-RX-API-DMAC10.html)
AU (2) AU2022319782A1 (cg-RX-API-DMAC10.html)
CA (2) CA3227845A1 (cg-RX-API-DMAC10.html)
IL (1) IL310432A (cg-RX-API-DMAC10.html)
MX (2) MX2024001396A (cg-RX-API-DMAC10.html)
WO (3) WO2023009751A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240040098A (ko) * 2021-07-30 2024-03-27 알.피.쉐러 테크놀러지즈 엘엘씨 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법
KR20250161707A (ko) * 2024-05-08 2025-11-18 아주대학교산학협력단 Nectin-2에 결합하는 항체 약물 접합체 및 이의 용도
WO2026039627A1 (en) * 2024-08-16 2026-02-19 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2682449C2 (ru) * 2012-09-19 2019-03-19 Иннейт Фарма Связывающие kir3dl2 агенты
US9310374B2 (en) * 2012-11-16 2016-04-12 Redwood Bioscience, Inc. Hydrazinyl-indole compounds and methods for producing a conjugate
CN115504924A (zh) * 2013-11-27 2022-12-23 雷德伍德生物科技股份有限公司 肼基-吡咯并化合物及用于生成缀合物的方法
WO2017083306A1 (en) * 2015-11-09 2017-05-18 R.P. Scherer Technologies, Llc Anti-cd22 antibody-maytansine conjugates and methods of use thereof
RU2746413C1 (ru) * 2017-03-21 2021-04-13 Пептрон, Инк. Антитело, специфически связывающееся с muc1, и его применение
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof
MX2020006010A (es) * 2017-12-11 2020-10-16 Triphase Res And Development Iii Corp Conjugados de anticuerpo anti-cd22-maitansina, combinaciones y metodos de uso de los mismos.
AU2019206207B2 (en) * 2018-01-15 2025-04-10 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
US12077583B2 (en) * 2018-05-09 2024-09-03 Nectin Therapeutics Ltd. Antibodies specific to human NECTIN4
WO2020154437A1 (en) * 2019-01-23 2020-07-30 R.P. Scherer Technologies, Llc Glycoside-containing peptide linkers for antibody-drug conjugates
KR20240040098A (ko) * 2021-07-30 2024-03-27 알.피.쉐러 테크놀러지즈 엘엘씨 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법

Similar Documents

Publication Publication Date Title
JP7403507B2 (ja) 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート
JP2022518743A5 (cg-RX-API-DMAC10.html)
JP7447183B2 (ja) 親水性抗体-薬物コンジュゲート
JP2024512986A5 (cg-RX-API-DMAC10.html)
JP2019142870A5 (cg-RX-API-DMAC10.html)
JP2022528851A5 (cg-RX-API-DMAC10.html)
US12042542B2 (en) Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer
JP2022530524A5 (cg-RX-API-DMAC10.html)
RU2136692C1 (ru) Уреидопроизводные нафталинфосфоновых кислот или их фармацевтически приемлемые соли и фармацевтическая композиция на их основе
JP2018512376A (ja) 抗体薬物コンジュゲート
JP2022541517A5 (cg-RX-API-DMAC10.html)
CN115504924A (zh) 肼基-吡咯并化合物及用于生成缀合物的方法
EA000006B1 (ru) Производные полипирролкарбоксамидонафталина, способ их получения и их применение
JP2020504180A (ja) β−ガラクトシドが導入された自己犠牲リンカーを含む化合物
RU2018120696A (ru) Конъюгаты анти-cd22 антитело-майтансин и способы их применения
RU2009121626A (ru) Соединения агонисты рецептора глюкагоноподобного белка-1 (glp-1r)
JP2024501537A5 (cg-RX-API-DMAC10.html)
JP2024509169A5 (cg-RX-API-DMAC10.html)
JP2023517939A (ja) オーロラaキナーゼの分解のためのタンパク質分解誘導キメラ分子(protac)
JP2023038189A (ja) ヘミアスタリン誘導体を含む抗体薬物複合体
JP2025516569A5 (cg-RX-API-DMAC10.html)
JP2017160205A (ja) 細胞毒性剤と細胞結合受容体との共役体
JP2024532677A5 (cg-RX-API-DMAC10.html)
JP2023551203A5 (cg-RX-API-DMAC10.html)
RU2024101910A (ru) Конъюгаты антитела и лекарственного средства и способы их использования